Martine A. Rothblatt net worth and biography

Martine Rothblatt Biography and Net Worth

Martine Rothblatt is an American entrepreneur, lawyer, and the founder of SiriusXM radio and United Therapeutics. She currently serves as chairman and CEO for United Therapeutics.

Rothblatt’s career trajectory began during her undergraduate studies, when, while traveling abroad, she visited the NASA tracking station in the Seychelles. Inspired by the possibilities of uniting the world via satellite communications, she returned to school and completed an undergraduate thesis on international direct-broadcast satellites.

She then went on to a four-year J.D. and M.B.A. program where she published articles on the law of satellite communications, prepared a business plan for the Hughes SPace and Communications Group, and was a regular contributor on the legal ramifications of space colonization for the OASIS newsletter.

Upon her graduation in 1981, she worked for the Washington D.C. law firm of Covington & Burling, representing the broadcasting industry before the Federal Communications Commission regarding direct broadcast satellites and spread spectrum communication. She was then retained by NASA and the National Academy of Sciences' Committee on Radio Frequencies, and Geostar Systems to handle business and regulatory matters related to the FCC.

In 1990, she co-founded Sirius Satellite Radio, but left shortly after the company's 1993 initial public offering. Ater her daughter received a life-threatening pulmonary arterial hypertension diagnosis in 1994, she moved into the biotech space, hoping to find more treatment options—at the time, there was just one drug. She founded United Therapeutics in 1996 which now sells five FDA-approved drugs for people with PAH.

Now a public company, United Therapeutics is working on genetic modification and pig cloning, attempting to create a successful lung transplant for humans.

Rothblatt is the co-inventor on six United Therapeutics patents related to treprostinil, and the inventor of our recently-awarded patent on a brain-computer interface device for patients with debilitating cognitive conditions.

Born Martin Rothblatt, she underwent gender reassignment surgery in 1994 and has since become a strong advocate for transgender rights. In 2019 she was recognized by Business Insider as one of the “Most Powerful LGBTQ+ People in Tech.” She was also recognized on Fast Company’s inaugural “Queer 50” list in 2020, recognizing LGBTQ women and nonbinary individuals who are leaders across industries including tech, finance, venture capital, media, and entertainment.

Rothblatt has received numerous other accolades for her roles, including recognition by Forbes in 2017 as one of the “100 Greates Living Business Minds of the Past Century.” In 2018, she received the UCLA Medal, the university’s highest award.

Rothblatt earned her B.A. in communication studies, as well as her M.B.A. and J.D. from the University of California, Los Angeles. She is married to realtor Bina Aspen, and the couple shares four children, one each from previous relationships and two together.

What is Martine A. Rothblatt's net worth?: The estimated net worth of Martine A. Rothblatt is at least $30,427.80 as of April 18th, 2024. Ms. Rothblatt owns 130 shares of United Therapeutics stock worth more than $30,428 as of April 23rd. This net worth approximation does not reflect any other investments that Ms. Rothblatt may own. Additionally, Ms. Rothblatt receives a salary of $5,320,000.00 as CEO at United Therapeutics. Learn More about Martine A. Rothblatt's net worth.
How old is Martine A. Rothblatt?: Ms. Rothblatt is currently 69 years old. There are 4 older executives and no younger executives at United Therapeutics. Learn More on Martine A. Rothblatt's age.
What is Martine A. Rothblatt's salary?: As the CEO of United Therapeutics Co., Ms. Rothblatt earns $5,320,000.00 per year. Learn More on Martine A. Rothblatt's salary.
How do I contact Martine A. Rothblatt?: The corporate mailing address for Ms. Rothblatt and other United Therapeutics executives is 1040 SPRING ST, SILVER SPRING MD, 20910. United Therapeutics can also be reached via phone at (301) 608-9292 and via email at [email protected]. Learn More on Martine A. Rothblatt's contact information.
Has Martine A. Rothblatt been buying or selling shares of United Therapeutics?: Over the course of the past ninety days, Martine A. Rothblatt has sold $10,514,595.20 in United Therapeutics stock. Most recently, Martine A. Rothblatt sold 3,600 shares of the business's stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $237.91, for a transaction totalling $856,476.00. Following the completion of the sale, the chief executive officer now directly owns 130 shares of the company's stock, valued at $30,928.30. Learn More on Martine A. Rothblatt's trading history.
Who are United Therapeutics' active insiders?: United Therapeutics' insider roster includes Christopher Causey (Director), Raymond Dwek (Director), Paul Mahon (EVP), Nilda Mesa (Director), Judy Olian (Director), Christopher Patusky (Director), Martine Rothblatt (CEO), and Louis Sullivan (Director). Learn More on United Therapeutics' active insiders.
Are insiders buying or selling shares of United Therapeutics?: During the last twelve months, insiders at the biotechnology company sold shares 40 times. They sold a total of 258,652 shares worth more than $59,646,475.02. The most recent insider tranaction occured on April, 18th when CEO Martine A Rothblatt sold 3,600 shares worth more than $856,476.00. Insiders at United Therapeutics own 12.5% of the company. Learn More about insider trades at United Therapeutics.
Information on this page was last updated on 4/18/2024.

Martine A. Rothblatt Insider Trading History at United Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/18/2024	Sell	3,600	$237.91	$856,476.00	130
4/16/2024	Sell	3,600	$232.05	$835,380.00	130
4/12/2024	Sell	3,600	$235.42	$847,512.00	130
4/10/2024	Sell	13,800	$237.27	$3,274,326.00	130
4/8/2024	Sell	5,060	$237.52	$1,201,851.20	130
4/4/2024	Sell	15,000	$233.27	$3,499,050.00	130
3/28/2024	Sell	14,125	$236.18	$3,336,042.50	130
3/26/2024	Sell	15,000	$248.33	$3,724,950.00	130
3/22/2024	Sell	15,000	$237.05	$3,555,750.00	130
3/19/2024	Sell	15,000	$236.59	$3,548,850.00	130
5/1/2023	Sell	8,000	$231.40	$1,851,200.00	130
4/28/2023	Sell	8,000	$229.32	$1,834,560.00	130
4/26/2023	Sell	8,000	$226.01	$1,808,080.00	130
4/24/2023	Sell	8,000	$228.64	$1,829,120.00	130
4/21/2023	Sell	8,000	$228.82	$1,830,560.00	130
4/19/2023	Sell	8,000	$226.12	$1,808,960.00	130
4/17/2023	Sell	8,000	$230.47	$1,843,760.00	130
4/13/2023	Sell	8,000	$230.69	$1,845,520.00	130
4/11/2023	Sell	8,000	$225.57	$1,804,560.00	130
4/6/2023	Sell	8,000	$229.12	$1,832,960.00	130
4/4/2023	Sell	8,000	$226.26	$1,810,080.00	130
3/30/2023	Sell	8,000	$217.14	$1,737,120.00	130
3/27/2023	Sell	8,000	$217.04	$1,736,320.00	130
3/24/2023	Sell	8,000	$217.95	$1,743,600.00	130
3/22/2023	Sell	8,000	$216.01	$1,728,080.00	130
3/20/2023	Sell	8,000	$223.96	$1,791,680.00	130
3/17/2023	Sell	8,000	$217.91	$1,743,280.00	130
3/9/2023	Sell	8,000	$222.63	$1,781,040.00	130
3/7/2023	Sell	8,000	$239.16	$1,913,280.00	121
3/2/2023	Sell	8,000	$244.50	$1,956,000.00	130
2/27/2023	Sell	8,000	$249.14	$1,993,120.00	130
2/24/2023	Sell	8,000	$249.27	$1,994,160.00	130
2/22/2023	Sell	8,000	$246.77	$1,974,160.00	130
2/13/2023	Sell	8,000	$254.76	$2,038,080.00	130
2/8/2023	Sell	8,000	$253.38	$2,027,040.00	130
1/31/2023	Sell	8,000	$261.50	$2,092,000.00	130
1/27/2023	Sell	8,000	$260.01	$2,080,080.00	130
1/25/2023	Sell	8,000	$264.21	$2,113,680.00	130
1/23/2023	Sell	8,000	$258.97	$2,071,760.00	130
1/19/2023	Sell	8,000	$259.60	$2,076,800.00	130
1/17/2023	Sell	8,000	$260.50	$2,084,000.00	130
1/13/2023	Sell	8,000	$261.52	$2,092,160.00	130
1/11/2023	Sell	8,000	$261.39	$2,091,120.00	130
1/9/2023	Sell	8,000	$267.86	$2,142,880.00	130
1/6/2023	Sell	8,000	$276.29	$2,210,320.00	130
12/27/2022	Sell	8,000	$274.34	$2,194,720.00	130
12/23/2022	Sell	8,000	$277.61	$2,220,880.00	130
12/20/2022	Sell	8,000	$272.20	$2,177,600.00	130
12/14/2022	Sell	6,310	$276.75	$1,746,292.50	130
12/12/2022	Sell	8,000	$279.27	$2,234,160.00	130
12/8/2022	Sell	8,000	$278.65	$2,229,200.00	130
12/6/2022	Sell	8,000	$274.29	$2,194,320.00	130
11/30/2022	Sell	8,000	$277.53	$2,220,240.00	130
11/28/2022	Sell	8,000	$270.07	$2,160,560.00	130
11/25/2022	Sell	8,000	$267.26	$2,138,080.00	130
11/23/2022	Sell	8,000	$268.56	$2,148,480.00	130
11/21/2022	Sell	8,000	$266.93	$2,135,440.00	130
11/18/2022	Sell	8,000	$263.97	$2,111,760.00	130
11/14/2022	Sell	8,000	$258.17	$2,065,360.00	130
11/8/2022	Sell	7,680	$262.70	$2,017,536.00	130
11/4/2022	Sell	8,000	$264.85	$2,118,800.00	130
5/31/2022	Sell	3,000	$230.85	$692,550.00	130
5/27/2022	Sell	3,000	$231.27	$693,810.00	130
5/25/2022	Sell	3,000	$223.58	$670,740.00	130
5/23/2022	Sell	3,000	$209.61	$628,830.00	130
12/29/2021	Sell	3,082	$212.49	$654,894.18
12/27/2021	Sell	3,082	$213.31	$657,421.42
12/22/2021	Sell	3,082	$202.44	$623,920.08
12/20/2021	Sell	3,082	$200.00	$616,400.00
11/24/2021	Sell	3,083	$200.64	$618,573.12
11/22/2021	Sell	3,083	$200.42	$617,894.86
11/15/2021	Sell	3,083	$203.45	$627,236.35
11/10/2021	Sell	3,083	$200.00	$616,600.00
11/8/2021	Sell	3,083	$200.94	$619,498.02
11/4/2021	Sell	3,083	$200.00	$616,600.00
7/8/2020	Sell	10,000	$117.91	$1,179,100.00	10,140
7/6/2020	Sell	10,000	$119.60	$1,196,000.00	10,140
7/2/2020	Sell	10,000	$120.73	$1,207,300.00	10,140
6/30/2020	Sell	10,000	$120.36	$1,203,600.00	10,140
6/26/2020	Sell	10,000	$121.00	$1,210,000.00	10,140
6/24/2020	Sell	30,000	$119.54	$3,586,200.00	10,140
6/22/2020	Sell	10,000	$117.81	$1,178,100.00	10,140
6/19/2020	Sell	20,000	$116.35	$2,327,000.00	10,140
6/17/2020	Sell	10,000	$117.82	$1,178,200.00	10,140
6/15/2020	Sell	10,000	$113.87	$1,138,700.00	10,140
6/12/2020	Sell	20,000	$115.42	$2,308,400.00	10,140
6/10/2020	Sell	30,000	$122.86	$3,685,800.00	10,140
6/5/2020	Sell	10,000	$123.59	$1,235,900.00	10,140
6/3/2020	Sell	10,000	$124.52	$1,245,200.00	10,140
6/1/2020	Sell	10,000	$119.28	$1,192,800.00	10,140
5/29/2020	Sell	10,000	$115.91	$1,159,100.00	10,140
5/27/2020	Sell	10,000	$115.90	$1,159,000.00	10,140
1/30/2019	Sell	14,108	$115.77	$1,633,283.16	7,194
1/28/2019	Sell	14,108	$115.37	$1,627,639.96	7,194
1/24/2019	Sell	7,054	$113.95	$803,803.30	7,194
1/22/2019	Sell	7,054	$113.35	$799,570.90	7,194
1/17/2019	Sell	14,108	$113.70	$1,604,079.60	7,194
1/15/2019	Sell	14,108	$114.85	$1,620,303.80	7,194
1/10/2019	Sell	14,108	$113.51	$1,601,399.08	7,194
1/8/2019	Sell	7,054	$113.16	$798,230.64	7,195
1/4/2019	Sell	7,055	$111.51	$786,703.05	1,540
4/9/2018	Sell	21,513	$110.88	$2,385,361.44	21,653
4/5/2018	Sell	21,512	$114.30	$2,458,821.60	21,652
4/3/2018	Sell	22,059	$114.44	$2,524,431.96	687
3/29/2018	Sell	43,024	$111.14	$4,781,687.36	21,652
3/22/2018	Sell	1,100	$110.01	$121,011.00	1,240
3/20/2018	Sell	301	$110.48	$33,254.48	21,652
3/16/2018	Sell	43,025	$111.11	$4,780,507.75	21,652
3/14/2018	Sell	21,512	$112.55	$2,421,175.60	21,652
12/8/2017	Sell	1	$136.16	$136.16	141
11/30/2017	Sell	1,241	$128.95	$160,026.95
11/24/2017	Sell	1,253	$124.07	$155,459.71
11/16/2017	Sell	7,061	$121.12	$855,228.32
11/9/2017	Sell	1,260	$121.46	$153,039.60	1,400
11/2/2017	Sell	1,269	$118.04	$149,792.76	1,409
10/26/2017	Sell	1,263	$120.38	$152,039.94	1,403
10/19/2017	Sell	1,265	$119.38	$151,015.70	1,405
10/12/2017	Sell	1,263	$120.20	$151,812.60
10/5/2017	Sell	1,256	$122.98	$154,462.88
9/28/2017	Sell	1,265	$119.70	$151,420.50	2,334
9/21/2017	Sell	1,274	$116.07	$147,873.18	2,343
9/14/2017	Sell	1,258	$122.08	$153,576.64	2,327
9/7/2017	Sell	1,232	$133.32	$164,250.24	2,301
8/31/2017	Sell	1,235	$130.49	$161,155.15	2,304
8/24/2017	Sell	1,238	$130.65	$161,744.70	2,307
8/17/2017	Sell	1,235	$131.95	$162,958.25	2,304
8/10/2017	Sell	2,176	$127.11	$276,591.36	3,245
8/3/2017	Sell	1,248	$126.41	$157,759.68	2,317
7/27/2017	Sell	1,247	$126.40	$157,620.80	2,316
7/20/2017	Sell	1,236	$131.62	$162,682.32	1,376
7/13/2017	Sell	1,238	$130.44	$161,484.72	1,378
7/6/2017	Sell	1,234	$132.29	$163,245.86	1,374
6/29/2017	Sell	1,237	$130.92	$161,948.04	1,377
6/22/2017	Sell	1,234	$132.32	$163,282.88	1,374
6/15/2017	Sell	1,238	$130.20	$161,187.60	1,378
6/8/2017	Sell	1,240	$129.60	$160,704.00	1,380
6/1/2017	Sell	1,251	$125.02	$156,400.02	1,391
5/25/2017	Sell	1,265	$119.40	$151,041.00	1,405
5/18/2017	Sell	1,261	$120.72	$152,227.92	1,401
5/11/2017	Sell	1,259	$122.00	$153,598.00	1,399
5/4/2017	Sell	1,258	$122.24	$153,777.92	1,398
4/27/2017	Sell	1,262	$120.78	$152,424.36	1,402
4/20/2017	Sell	1,260	$121.14	$152,636.40	1,400
4/13/2017	Sell	1,258	$122.12	$153,626.96	1,398
4/6/2017	Sell	1,257	$122.39	$153,844.23	1,397
3/30/2017	Sell	1,230	$134.56	$165,508.80	1,370
3/23/2017	Sell	1,219	$139.33	$169,843.27	1,359
3/16/2017	Sell	1,218	$140.16	$170,714.88	1,358
3/9/2017	Sell	1,206	$146.72	$176,944.32	1,346
3/2/2017	Sell	1,203	$148.49	$178,633.47	1,343
2/23/2017	Sell	1,208	$145.16	$175,353.28	1,348
2/16/2017	Sell	1,173	$167.92	$196,970.16	1,313
1/12/2017	Sell	1,214	$142.37	$172,837.18	1,354
1/5/2017	Sell	1,208	$145.73	$176,041.84	1,348
12/29/2016	Sell	1,211	$143.63	$173,935.93	1,351
12/22/2016	Sell	1,218	$140.23	$170,800.14	1,358
12/15/2016	Sell	1,212	$143.11	$173,449.32	1,352
12/8/2016	Sell	1,236	$131.78	$162,880.08	1,376
12/1/2016	Sell	1,246	$126.86	$158,067.56	1,386
11/25/2016	Sell	1,233	$132.81	$163,754.73	1,373
11/17/2016	Sell	1,232	$132.94	$163,782.08	1,372
11/10/2016	Sell	1,240	$129.82	$160,976.80	1,380
11/3/2016	Sell	1,272	$116.94	$148,747.68	1,412
10/27/2016	Sell	1,272	$117.06	$148,900.32	1,412
10/20/2016	Sell	1,282	$113.30	$145,250.60	1,422
10/13/2016	Sell	1,269	$117.99	$149,729.31	1,409
10/6/2016	Sell	1,260	$121.17	$152,674.20	1,400
9/29/2016	Sell	1,272	$116.94	$148,747.68	1,412
9/22/2016	Sell	1,249	$125.87	$157,211.63	1,389
9/15/2016	Sell	1,258	$122.34	$153,903.72	1,398
9/8/2016	Sell	1,254	$123.44	$154,793.76	1,394
9/1/2016	Sell	1,257	$122.81	$154,372.17	1,397
8/25/2016	Sell	1,250	$125.29	$156,612.50	1,390
8/18/2016	Sell	1,249	$125.88	$157,224.12	1,389
8/11/2016	Sell	1,253	$124.09	$155,484.77	1,393
8/4/2016	Sell	1,249	$125.78	$157,099.22	1,389
7/28/2016	Sell	1,271	$117.05	$148,770.55	1,411
7/21/2016	Sell	1,284	$112.77	$144,796.68	1,424
7/14/2016	Sell	1,292	$110.05	$142,184.60	1,432
7/7/2016	Sell	1,293	$109.87	$142,061.91	1,433
6/30/2016	Sell	1,308	$105.10	$137,470.80	1,548
6/23/2016	Sell	1,312	$104.07	$136,539.84	1,552
6/16/2016	Sell	1,308	$105.18	$137,575.44	1,548
6/9/2016	Sell	1,277	$114.99	$146,842.23	1,517
6/2/2016	Sell	1,261	$120.79	$152,316.19	1,501
5/26/2016	Sell	5,547	$117.57	$652,160.79	5,787
5/19/2016	Sell	5,546	$110.75	$614,219.50	5,786
5/12/2016	Sell	5,547	$109.02	$604,733.94	5,787
5/5/2016	Sell	5,546	$107.79	$597,803.34	5,786
4/28/2016	Sell	5,547	$106.81	$592,475.07	5,787
4/21/2016	Sell	5,546	$115.74	$641,894.04	5,786
4/14/2016	Sell	5,547	$114.32	$634,133.04	5,787
4/7/2016	Sell	5,546	$113.31	$628,417.26	5,786
3/24/2016	Sell	5,546	$110.80	$614,496.80	5,786
3/17/2016	Sell	5,547	$118.22	$655,766.34	5,787
3/10/2016	Sell	5,546	$123.41	$684,431.86	5,786
3/3/2016	Sell	5,547	$126.78	$703,248.66	5,787
2/25/2016	Sell	5,546	$122.45	$679,107.70	5,786
2/18/2016	Sell	5,547	$128.26	$711,458.22	5,787
2/11/2016	Sell	5,546	$120.47	$668,126.62	240
2/4/2016	Sell	5,547	$122.13	$677,455.11	240
1/28/2016	Sell	5,546	$124.00	$687,704.00	240
1/21/2016	Sell	5,547	$127.00	$704,469.00	240
1/14/2016	Sell	5,546	$135.94	$753,923.24	240
1/7/2016	Sell	5,547	$145.84	$808,974.48	240
12/24/2015	Sell	5,546	$159.58	$885,030.68	240
12/17/2015	Sell	5,546	$158.49	$878,985.54	240
12/10/2015	Sell	5,546	$154.49	$856,801.54	240
12/3/2015	Sell	5,546	$154.49	$856,801.54	240
11/27/2015	Sell	5,561	$153.81	$855,337.41	240
11/19/2015	Sell	9,661	$148.56	$1,435,238.16	240
11/12/2015	Sell	4,115	$147.72	$607,867.80	240
11/5/2015	Sell	4,115	$149.16	$613,793.40	240
10/29/2015	Sell	9,662	$141.89	$1,370,941.18	240
10/28/2015	Sell	2,211	$136.58	$301,978.38	240
10/26/2015	Sell	2,592	$127.13	$329,520.96	240
10/22/2015	Sell	9,662	$122.40	$1,182,628.80	240
10/21/2015	Sell	2,211	$123.63	$273,345.93	240
10/19/2015	Sell	2,592	$126.71	$328,432.32	240
10/15/2015	Sell	9,662	$126.22	$1,219,537.64	240
10/14/2015	Sell	2,211	$123.53	$273,124.83	240
10/12/2015	Sell	2,592	$123.51	$320,137.92	240
10/8/2015	Sell	9,662	$122.48	$1,183,401.76	240
10/7/2015	Sell	2,211	$120.88	$267,265.68	240
10/5/2015	Sell	2,592	$126.88	$328,872.96	240
10/1/2015	Sell	6,326	$131.11	$829,401.86	240
9/29/2015	Sell	2,592	$134.25	$347,976.00	240
9/24/2015	Sell	9,662	$139.26	$1,345,530.12	240
9/23/2015	Sell	2,211	$142.05	$314,072.55	240
9/21/2015	Sell	2,592	$150.81	$390,899.52	240
9/17/2015	Sell	9,662	$152.02	$1,468,817.24	240
9/16/2015	Sell	2,211	$151.93	$335,917.23	240
9/14/2015	Sell	2,592	$153.08	$396,783.36	240
9/10/2015	Sell	4,115	$152.95	$629,389.25	240
9/9/2015	Sell	2,211	$152.77	$337,774.47	240
9/8/2015	Sell	2,592	$152.80	$396,057.60	240
9/3/2015	Sell	9,662	$153.67	$1,484,759.54	240
9/2/2015	Sell	2,211	$151.12	$334,126.32	240
8/31/2015	Sell	2,592	$153.50	$397,872.00	240
8/27/2015	Sell	9,662	$160.37	$1,549,494.94	240
8/26/2015	Sell	2,211	$155.47	$343,744.17	240
8/24/2015	Sell	2,592	$155.36	$402,693.12	240
8/20/2015	Sell	9,662	$166.58	$1,609,495.96	240
8/19/2015	Sell	2,211	$167.13	$369,524.43	240
8/17/2015	Sell	2,592	$166.61	$431,853.12
8/13/2015	Sell	9,662	$165.05	$1,594,713.10
7/27/2015	Sell	2,592	$166.38	$431,256.96
7/23/2015	Sell	4,115	$176.38	$725,803.70
7/22/2015	Sell	2,211	$174.55	$385,930.05
7/20/2015	Sell	2,592	$177.92	$461,168.64
7/16/2015	Sell	9,662	$175.51	$1,695,777.62
7/15/2015	Sell	2,211	$176.77	$390,838.47
7/13/2015	Sell	2,592	$172.42	$446,912.64
7/9/2015	Sell	9,662	$168.04	$1,623,602.48
7/8/2015	Sell	2,211	$167.13	$369,524.43
7/6/2015	Sell	2,592	$170.66	$442,350.72
7/2/2015	Sell	6,326	$170.69	$1,079,784.94
6/29/2015	Sell	2,592	$172.86	$448,053.12
6/25/2015	Sell	9,662	$176.91	$1,709,304.42
6/24/2015	Sell	2,211	$179.68	$397,272.48
6/22/2015	Sell	2,592	$188.64	$488,954.88
6/18/2015	Sell	9,662	$185.72	$1,794,426.64
6/17/2015	Sell	2,211	$185.25	$409,587.75
6/15/2015	Sell	2,592	$185.15	$479,908.80
6/11/2015	Sell	9,662	$183.76	$1,775,489.12
6/10/2015	Sell	2,211	$180.87	$399,903.57
6/8/2015	Sell	2,592	$181.34	$470,033.28
6/4/2015	Sell	9,662	$181.94	$1,757,904.28
6/3/2015	Sell	2,211	$184.49	$407,907.39
6/1/2015	Sell	2,592	$182.66	$473,454.72
5/28/2015	Sell	9,662	$180.88	$1,747,662.56
5/27/2015	Sell	2,211	$184.39	$407,686.29
5/26/2015	Sell	2,592	$182.64	$473,402.88
5/21/2015	Sell	9,662	$182.44	$1,762,735.28
5/20/2015	Sell	2,211	$182.80	$404,170.80
5/18/2015	Sell	2,592	$177.79	$460,831.68
5/14/2015	Sell	9,662	$174.07	$1,681,864.34
5/13/2015	Sell	2,211	$175.41	$387,831.51
5/11/2015	Sell	2,592	$179.55	$465,393.60
5/7/2015	Sell	9,662	$169.86	$1,641,187.32
5/6/2015	Sell	2,211	$169.22	$374,145.42
5/4/2015	Sell	2,592	$169.81	$440,147.52
4/30/2015	Sell	9,662	$162.36	$1,568,722.32
4/29/2015	Sell	2,211	$164.29	$363,245.19
4/27/2015	Sell	2,592	$177.62	$460,391.04
4/23/2015	Sell	9,662	$187.35	$1,810,175.70
4/22/2015	Sell	2,211	$187.49	$414,540.39
4/20/2015	Sell	2,592	$184.86	$479,157.12
4/16/2015	Sell	11,873	$187.01	$2,220,369.73
4/13/2015	Sell	2,592	$187.86	$486,933.12
4/9/2015	Sell	9,662	$183.09	$1,769,015.58
4/8/2015	Sell	2,211	$181.91	$402,203.01
4/6/2015	Sell	2,592	$176.20	$456,710.40
4/2/2015	Sell	11,873	$173.43	$2,059,134.39
3/30/2015	Sell	2,592	$177.22	$459,354.24
3/26/2015	Sell	9,662	$167.03	$1,613,843.86
3/25/2015	Sell	2,211	$173.67	$383,984.37
3/23/2015	Sell	2,592	$177.76	$460,753.92
3/18/2015	Sell	2,211	$174.64	$386,129.04
3/16/2015	Sell	2,592	$170.97	$443,154.24
3/12/2015	Sell	11,873	$162.94	$1,934,586.62
3/9/2015	Sell	2,592	$160.51	$416,041.92
3/5/2015	Sell	9,662	$159.75	$1,543,504.50
3/4/2015	Sell	2,211	$157.63	$348,519.93
3/2/2015	Sell	2,592	$155.32	$402,589.44
2/26/2015	Sell	9,662	$155.23	$1,499,832.26
2/25/2015	Sell	2,211	$159.35	$352,322.85
2/23/2015	Sell	2,592	$156.08	$404,559.36
2/19/2015	Sell	9,662	$155.99	$1,507,175.38
2/17/2015	Sell	2,592	$152.28	$394,709.76
2/12/2015	Sell	9,662	$146.01	$1,410,748.62
2/11/2015	Sell	2,211	$147.29	$325,658.19
2/9/2015	Sell	2,592	$143.32	$371,485.44
2/5/2015	Sell	11,773	$141.07	$1,660,817.11
1/29/2015	Sell	9,662	$143.29	$1,384,467.98
1/28/2015	Sell	2,211	$145.49	$321,678.39
1/26/2015	Sell	2,592	$145.89	$378,146.88
1/22/2015	Sell	11,873	$146.76	$1,742,481.48
1/20/2015	Sell	2,592	$145.06	$375,995.52
1/15/2015	Sell	9,662	$137.51	$1,328,621.62
1/14/2015	Sell	2,211	$135.18	$298,882.98
1/12/2015	Sell	2,592	$132.00	$342,144.00
1/8/2015	Sell	9,662	$128.31	$1,239,731.22
1/7/2015	Sell	2,211	$126.04	$278,674.44
1/5/2015	Sell	2,592	$126.88	$328,872.96
1/2/2015	Sell	9,662	$126.53	$1,222,532.86
12/31/2014	Sell	2,211	$131.35	$290,414.85
12/29/2014	Sell	2,592	$131.75	$341,496.00
12/26/2014	Sell	9,662	$131.85	$1,273,934.70
12/24/2014	Sell	2,211	$130.35	$288,203.85
12/22/2014	Sell	2,592	$133.45	$345,902.40
12/18/2014	Sell	9,662	$129.06	$1,246,977.72
12/17/2014	Sell	2,211	$126.04	$278,674.44
12/15/2014	Sell	2,592	$129.75	$336,312.00
12/11/2014	Sell	9,662	$130.98	$1,265,528.76
12/10/2014	Sell	2,211	$132.77	$293,554.47
12/8/2014	Sell	2,592	$132.34	$343,025.28
12/4/2014	Sell	11,873	$131.32	$1,559,162.36
12/1/2014	Sell	2,592	$132.92	$344,528.64
11/28/2014	Sell	11,873	$132.77	$1,576,378.21
11/24/2014	Sell	2,592	$130.72	$338,826.24
11/20/2014	Sell	9,662	$128.86	$1,245,045.32
11/19/2014	Sell	2,211	$128.69	$284,533.59
11/17/2014	Sell	2,592	$125.65	$325,684.80
11/13/2014	Sell	9,662	$124.79	$1,205,720.98
11/12/2014	Sell	2,211	$122.88	$271,687.68
11/10/2014	Sell	2,592	$125.14	$324,362.88
11/6/2014	Sell	4,115	$125.33	$515,732.95
11/5/2014	Sell	2,211	$124.31	$274,849.41
11/3/2014	Sell	2,592	$127.49	$330,454.08
10/30/2014	Sell	9,662	$130.42	$1,260,118.04
10/29/2014	Sell	2,211	$131.10	$289,862.10
10/27/2014	Sell	2,592	$132.16	$342,558.72
10/23/2014	Sell	11,873	$129.97	$1,543,133.81
10/13/2014	Sell	2,592	$124.31	$322,211.52
10/9/2014	Sell	9,662	$129.97	$1,255,770.14
10/8/2014	Sell	2,211	$131.50	$290,746.50
10/6/2014	Sell	2,592	$129.32	$335,197.44
10/2/2014	Sell	9,662	$127.72	$1,234,030.64
10/1/2014	Sell	2,211	$127.40	$281,681.40
9/25/2014	Sell	5,547	$134.26	$744,740.22
9/18/2014	Sell	9,662	$127.35	$1,230,455.70
9/15/2014	Sell	50,000	$124.52	$6,226,000.00
9/11/2014	Sell	9,662	$120.79	$1,167,072.98
9/10/2014	Sell	50,000	$120.01	$6,000,500.00
9/4/2014	Sell	9,662	$112.87	$1,090,549.94
8/28/2014	Sell	7,014	$92.46	$648,514.44
8/21/2014	Sell	9,640	$93.13	$897,773.20
8/14/2014	Sell	4,115	$88.39	$363,724.85
8/7/2014	Sell	4,115	$88.40	$363,766.00
7/31/2014	Sell	3,933	$90.95	$357,706.35
7/24/2014	Sell	9,228	$93.15	$859,588.20
7/17/2014	Sell	3,833	$90.87	$348,304.71
7/10/2014	Sell	9,187	$92.33	$848,235.71
7/3/2014	Sell	3,833	$91.37	$350,221.21
6/26/2014	Sell	3,833	$87.23	$334,352.59
6/19/2014	Sell	3,833	$85.68	$328,411.44
6/12/2014	Sell	9,066	$98.22	$890,462.52
6/5/2014	Sell	9,066	$96.46	$874,506.36
5/29/2014	Sell	9,066	$95.27	$863,717.82
10/31/2013	Sell	3,833	$86.89	$333,049.37
10/24/2013	Sell	3,833	$83.77	$321,090.41
10/17/2013	Sell	3,833	$81.84	$313,692.72
10/3/2013	Sell	3,833	$84.20	$322,738.60
9/12/2013	Sell	3,833	$76.98	$295,064.34
9/5/2013	Sell	3,833	$73.63	$282,223.79
8/1/2013	Sell	3,833	$75.97	$291,193.01
7/25/2013	Sell	3,833	$71.45	$273,867.85
7/18/2013	Sell	3,833	$68.96	$264,323.68
7/11/2013	Sell	3,837	$67.94	$260,685.78
7/5/2013	Sell	3,863	$67.28	$259,902.64
12/28/2012	Buy	4,167	$52.40	$218,350.80
12/26/2012	Buy	6,000	$52.40	$314,400.00
12/21/2012	Buy	9,000	$51.85	$466,650.00

Martine A. Rothblatt Buying and Selling Activity at United Therapeutics

United Therapeutics Company Overview

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Today's Range

Now: $234.06

$233.77

$238.55

50 Day Range

MA: $232.07

$213.75

$249.51

2 Week Range

Now: $234.06

$204.44

$261.54

Volume

552,487 shs

Average Volume

520,187 shs

Market Capitalization

$11.01 billion

P/E Ratio

11.80

Dividend Yield

N/A

Beta

0.52

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

Martine Rothblatt Biography and Net Worth

What is Martine A. Rothblatt's net worth?

How old is Martine A. Rothblatt?

What is Martine A. Rothblatt's salary?

How do I contact Martine A. Rothblatt?

Has Martine A. Rothblatt been buying or selling shares of United Therapeutics?

Who are United Therapeutics' active insiders?

Are insiders buying or selling shares of United Therapeutics?